门静脉高压症合并肝癌的外科治疗

Surgical treatment of portal hypertension patients with primary hepatic cancer

报道门静脉高压症 (PHT)合并肝癌 (PHC)患者 9例 ,施行肝叶切除术及脾切除、断流术 8例 ,另 1例因左、右肝均有癌灶 ,仅行剖腹探查术。术后随访 6个月至 3年 ,1例多发肿瘤患者于术后 9个月死亡 ;1例肝癌复发并肺内转移者于术后 18个月死亡 ;余 7例肝癌无复发 ,未发生消化道出血 ,情况良好 ,其中 5例已恢复术前工作。提示 PHT合并 PHC患者只要条件允许 ,应同期施行肝叶切除加脾切除、断流术 ,可延长生存时间 ,改善生活质量。

cases of portal hypertension(PHT)with primary hepatic cancer(PHC)were surgically treated Eight patients underwent hepatectomy and splenectomy plus pericardiac devascularizasion(PCDV) One patient underwent laparotomy because multiple liver tumors were found after examination Eight patients were followed up 6 to 36 months after surgery,one patient underwent laparotomy and died 9 months after surgery One died of intrahepatic recurrence and lung metastasis after 18 months of surgery The other seven patients had no intrahepatic recurrence and no recurrent hemorrhage from esophageal varices after surgery For PHT to with PHC,hepatectomy and splenectomy plus PCDV should be performed to prolong survival time if they can tolerate the operation